Efficacy of Systane Balance eye drop on tear lipid layer thickness with dry eye patients accompanied with meibomian gland dysfunction

Efficacy of Systane Balance eye drop on tear lipid layer thickness with dry eye patients accompanied with meibomian gland dysfunction - Efficacy of Systane Balance on lipid layer with meibomian gland dysfunction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022744

Enrollment

Registered

2016-06-16

Start date

2016-06-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye accompanied with meibomian gland dysfunction

Interventions

Systaine Balance eye drop/artificial tears 4 times a day for 28 days artificial tears 4 times a day for 28 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dry eye accompanied with meibomian gland dysfunction

Exclusion criteria

Exclusion criteria: Other ocular diseases, the history of ocular surgery within 3 months

Design outcomes

Primary

Measure	Time frame
Lipid layer thickness (pre, 15 min, 30 min, 60 min)	—

Secondary

Measure	Time frame
Symptoms,tear film breakup time, meiboscore, Schirmer test, tear meniscus height, non-invasive breakup time	—

Countries

Japan

Contacts

Public ContactReiko Arita

Itoh Clinic Ophthalmology

arita.reiko@gmail.com048-686-5588

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026